Please assess the completion status of the following clinical trial:

Trial Title: Trident II Revision Outcomes Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~A. Patient has signed an IRB approved, study specific Informed Patient Consent Form.~B. Patient is a male or non-pregnant female age 18-85 years of age at the time of study device implantation.~C. Patient is a candidate for a revision of a failed acetabular component with a cementless acetabular component.~D. Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations.~Exclusion Criteria:~E. Patient has a Body Mass Index (BMI) \> 45. F. Patient is diagnosed with Inflammatory Arthritis. G. Patient has a non-Stryker retained stem. H. Patient has an active or suspected latent infection in or about the affected hip joint at time of study device implantation.~I. Patient has a mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care.~J. Patient has compromised bone stock which cannot provide adequate support and/or fixation to the prosthesis.~K. Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration.~L. Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days). M. Patient has a known sensitivity to device materials. N. Patient is a prisoner.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Trident II Tritanium Acetabular Shell for Revision (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).